Bio Essence Corporation (BIOE)

Bio Essence Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	0.9	-1.31	-0.97	-0.81	-0.65
Depreciation & Amortization	0	0	0	0.01	0.04
Loss (Gain) From Sale of Assets	-	0	0.01	-	-0
Asset Writedown & Restructuring Costs	-	1.05	-	-	-
Provision & Write-off of Bad Debts	-	-	-	-	0.01
Other Operating Activities	0.04	0.45	0.31	0.5	-0.01
Change in Accounts Receivable	-0.02	-0.01	-	0	0.02
Change in Inventory	-	-	-	0.03	0.06
Change in Accounts Payable	0.03	0.01	-0.01	-0.02	0.01
Change in Income Taxes	-0	-	-	-0	-0.01
Change in Other Net Operating Assets	0.62	0.82	-0.25	-0.22	-0.76
Operating Cash Flow	1.57	0.62	-1.03	-0.7	-1.29
Operating Cash Flow Growth	151.62%	-	-	-	-
Capital Expenditures	-	-	-0	-0	-0.12
Sale of Property, Plant & Equipment	-	-	-	-	0
Divestitures	-	-0	-	-	-
Other Investing Activities	-	-	-0.09	-0.06	-
Investing Cash Flow	-	-0	-0.09	-0.06	-0.12
Short-Term Debt Issued	0.77	-	1.18	0.78	1.29
Long-Term Debt Issued	-	-	-	0.06	0.17
Total Debt Issued	0.77	-	1.18	0.84	1.45
Short-Term Debt Repaid	-2.34	-0.61	-	-	-0.04
Long-Term Debt Repaid	-0	-0	-0	-0	-0
Total Debt Repaid	-2.34	-0.61	-0	-0	-0.05
Net Debt Issued (Repaid)	-1.57	-0.61	1.18	0.84	1.41
Other Financing Activities	-	-0.01	-0.07	-0.07	-
Financing Cash Flow	-1.57	-0.62	1.11	0.77	1.41
Net Cash Flow	-0	0	-0.01	0.01	-0.01
Free Cash Flow	1.57	0.62	-1.03	-0.71	-1.41
Free Cash Flow Growth	151.62%	-	-	-	-
Free Cash Flow Margin	82.73%	192.59%	-	-113.74%	-159.19%
Free Cash Flow Per Share	0.04	0.02	-0.03	-0.02	-0.04
Cash Interest Paid	0	0.01	0.02	0.01	0.04
Cash Income Tax Paid	0	0	0	0	0
Levered Free Cash Flow	0.81	0.12	-0.33	-0.25	-0.85
Unlevered Free Cash Flow	0.81	0.13	-0.33	-0.24	-0.83
Change in Working Capital	0.63	0.82	-0.26	-0.2	-0.68

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.